Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine on Reinforcement Learning and Social Cognition in Healthy Young People
NCT07456501Not yet recruiting
- Sponsor
- University of Oxford
- Start
- Mar 2026
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in major depressive disorder (MDD) comparing Fluoxetine with Placebo (2 arms). Primary endpoint: Facial Expression Recognition Task at 7 days. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
fluoxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT07456501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07456501.